White label ELPA - ClinicalTrials.eu

Study of Retatrutide for Patients with Type 2 Diabetes and Obesity or Overweight

Not recruiting

3 1
Investigated diseases:
- Type 2 diabetes mellitus
Investigated drugs:
- Ly3437943 Sodium
Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

Not recruiting

3 1 1 1
Investigated diseases:
- Macular oedema
- Retinal vein occlusion
Investigated drugs:
- Fluorescein Sodium
- Aflibercept
+8
Study of MK-7684A, Etoposide, and Platinum Drugs for Patients with Extensive-Stage Small Cell Lung Cancer

Not recruiting

3 1 1
Investigated diseases:
- Small cell lung cancer
Investigated drugs:
+8
Study on Long-Term Safety of Ligelizumab for Patients with Food Allergies

Not recruiting

3 1 1
Investigated diseases:
- Food allergy
Investigated drugs:
Study of Tislelizumab, LBL-007, and BGB-15025 in Patients with Advanced Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
- Non-small cell lung cancer metastatic
Investigated drugs:
Study on the Effects of Pegozafermin and Simvastatin for Patients with Severe High Triglycerides

Not recruiting

3 1 1
Investigated diseases:
- Hypertriglyceridaemia
Investigated drugs:
- Bio89-100
- Simvastatin
+5
Study on Long-Term Safety of Soticlestat for Adults and Children with Developmental Epileptic Encephalopathies

Not recruiting

2 1 1
Investigated diseases:
Investigated drugs:
- Soticlestat
Study on the Effects of Retatrutide for Patients with Severe Obesity and Cardiovascular Disease

Not recruiting

3 1
Investigated diseases:
- Cardiovascular disorder
- Obesity
Investigated drugs:
- Ly3437943 Sodium
Study Comparing Tisagenlecleucel with Standard Treatment for Adults with Relapsed or Refractory Follicular Lymphoma

Not recruiting

3 1 1 1
Investigated drugs:
+1
Study on the Safety and Effectiveness of Deucravacitinib for Patients with Active Discoid and/or Subacute Cutaneous Lupus Erythematosus

Not recruiting

2 1
Investigated diseases:
Investigated drugs:
- Deucravacitinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies